Literature DB >> 12000825

Decisions about voriconazole versus liposomal amphotericin B.

Thomas J Walsh, Jeannette Lee, William E Dismukes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12000825     DOI: 10.1056/NEJM200205093461915

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection.

Authors:  Jean Klastersky; Marianne Paesmans
Journal:  Support Care Cancer       Date:  2006-09-12       Impact factor: 3.603

2.  Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.

Authors:  Jutta Auberger; Cornelia Lass-Flörl; Hanno Ulmer; Elisabeth Nogler-Semenitz; Johannes Clausen; Eberhard Gunsilius; Hermann Einsele; Günther Gastl; David Nachbaur
Journal:  Int J Hematol       Date:  2008-11-05       Impact factor: 2.490

Review 3.  Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Authors:  Marit D Moen; Katherine A Lyseng-Williamson; Lesley J Scott
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 4.  Newer systemic antifungal agents : pharmacokinetics, safety and efficacy.

Authors:  Helen W Boucher; Andreas H Groll; Christine C Chiou; Thomas J Walsh
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 5.  Current and future therapeutic options in the management of invasive aspergillosis.

Authors:  Suganthini Krishnan-Natesan; Pranatharthi H Chandrasekar
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  Utilization and comparative effectiveness of caspofungin and voriconazole early after market approval in the U.S.

Authors:  Sibel Ascioglu; K Arnold Chan
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.